Articles Archives - Page 486 of 758

ThursdayJan 28, 2021 3:39 pm

HYB Holding Corp. (HYBG) Is ‘One to Watch’

HYB Holding Corp.’s subsidiary, Mediscan Inc., offers technology that can turn 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views Mediscan’s technology has multiple applications in lung, cardiac and musculoskeletal imaging and related applications A portable ultrasound scanner equipped with the Mediscan application can help detect and diagnose lung and cardiac tissue damage in COVID-19 patients, who cannot undergo regular imaging procedures while contagious Mediscan recently filed a provisional patent application with the United States Patent and Trademark Office for a System Method, Apparatus, and Computer Program Product…

ThursdayJan 28, 2021 3:20 pm

CannAssist International Corp. (CNSC) Addresses CBD Absorption Issues with Proprietary CiBiDinol Technology

CBD products in oil-based form have compromised bioavailability, according to experts CNSC's Xceptol CBD products created with proprietary CiBiDinol technology that addresses absorption issues for superior efficacy Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Growing in popularity in a myriad of markets, cannabidiol (“CBD”) is a phytocannabinoid that can mimic natural endocannabinoids in the human body for various therapeutic effects. Growing awareness around the use of oil-based CBD has led to skyrocketing popularity among the mainstream public despite bioavailability concerns among healthcare professionals and doctors (https://ibn.fm/d0Kab). CannAssist International (OTCQB:…

ThursdayJan 28, 2021 2:12 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost 14,000 women will die from the disease (https://ibn.fm/4yfJn). Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women; ovarian cancer causes more deaths than any other cancer of the female reproductive…

ThursdayJan 28, 2021 11:43 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Increases Private Placement, Begins Trading on OTC Market

Pure Extracts upsizes private placement to total 16,900,000 special warrants at price of $0.505. PULL also received approval from OTC Markets, is trading on OTC Market under ticker symbol PRXTF. Trading under new OTC ticker is “major step forward,” says Company CEO. Pure Extracts Technologies (CSE PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has increased its non-brokered private placement offering of special warrants; the original offering was announced on Dec. 16, 2020. The company also received approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF. The Company observed that the…

WednesdayJan 27, 2021 3:45 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

WednesdayJan 27, 2021 1:08 pm

Green Hygienics Holdings (GRYN) Leverages FDA Registration, USDA/CCOF Certification as Powerful Competitive Differentiator

Green Hygienics poised to become most highly certified hemp company in industry to differentiate itself from competition Anticipating tightening of regulatory standards, GRYN already achieved FDA registration and USDA/CCOF certification proving highest standards of product quality, transparency and safety With certifications to prove high-quality products, Green Hygienics appears ideally positioned to offer growth potential in increasingly quality-aware market As an innovative technology-driven enterprise, Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, and manufacturing of pharmaceutical-grade bioactive cannabinoids. Poised to bring safe and consistent products to market and thus change…

TuesdayJan 26, 2021 2:44 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025 MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plant Company seems well positioned within biopesticides market expected to achieve fastest growth The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the industry was valued at $4.3 billion in 2020 and is projected to almost double its size in the next five years — reaching $8.5 billion by 2025 and growing at a CAGR of…

TuesdayJan 26, 2021 2:27 pm

PacRoots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Leveraging Cannabis Market Shift by Producing “Super Elite” Strains

Rapidly growing cannabis market evolving to include diverse clientele seeking unique strains PACR uses genetics-first approach to cultivate exclusive high-yield strains with varying cannabinoid profiles PACR catalog features 350 tested cultivars, including 50 super-elite strains prized for unique properties Smoking marijuana decades ago traditionally meant rolling one type of cannabis that was grown outdoors under mostly natural conditions. Decades later, the market has completely transformed to accommodate the needs of savvy consumers who understand different strains and their varying effects. PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated to producing premium-quality strains and products through a genetics-focused…

TuesdayJan 26, 2021 2:11 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing and has after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both…

MondayJan 25, 2021 1:13 pm

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

UME commited to offering high-quality COVID-19 services, solutions and supplies. To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical. CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers. Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes the infectious disease, is likely here for the long haul (https://ibn.fm/1idh8). United Medical Equipment Business Solutions Network ("UME") is here for the long haul too, commited to offering high-quality COVID-19 services, solutions and supplies.…

Site Search

Company Search

Category: Articles